Live tape
Top 8, mentions 7d16,902MSFT3,279 mentions▲ +0.09GOOGL2,368 mentions▲ +0.05AAPL2,337 mentions▲ +0.07META2,188 mentions▲ +0.04SNDK1,989 mentions▲ +0.06NVDA1,697 mentions▲ +0.07SPCX1,658 mentions▲ +0.06AMZN1,386 mentions▲ +0.09

Equity · Healthcare

PTCT

PTC Therapeutics, Inc. · NasdaqGS

$79.00 +0.55% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView

The chart above plots the price of PTCT over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 55 sessions over that window: $65.00 on 4 May 2026 through $79.00 on 17 July 2026. Finazon · prior-day close.

Market cap $6.6B
P/E (TTM) 303.9
52-week range $43.30 – $90.00
Avg volume 361.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 31, 2026

PTCT insider trades

SEC Form 4 · last 90 days · newest reported trade 28 Jul 2026
Open-market buys 0
Open-market sells 16
Net sold $16.63M
Non-trade filings 16
Date Insider Type Shares Value
14 Jul 2026 Gravier Pierre CHIEF FINANCIAL OFFICER Sell 3,494 $281K
09 Jul 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 2,464 $222K
09 Jul 2026 Smith Mary L. Director Sell 15,834 $1.43M
07 Jul 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 24,613 $2.19M
06 Jul 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 22,161 $1.91M
06 Jul 2026 Boulding Mark Elliott EXEC. VP AND CLO Sell 5,079 $432K

Showing the 12 most recent of 32 filings in this window. The figures above count all of them.

Compensation mechanics (6 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
28 Jul 2026 Sollie-Zetlmayer Hege Elisabeth Director Award 6,000
09 Jul 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Option exercise 2,464 $115K
09 Jul 2026 Smith Mary L. Director Option exercise 15,834 $680K
07 Jul 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Option exercise 24,613 $970K
06 Jul 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Option exercise 22,161 $848K
06 Jul 2026 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 5,079 $220K

PTCT reported financials

SEC EDGAR XBRL

PTCT reported revenue of $1.7B for the fiscal year ended 31 Dec 2025. Net income over the same period was $682.6M.

Figure Reported Period
Revenue $1.7B 31 Dec 2025 fiscal year
Net income $682.6M 31 Dec 2025 fiscal year
Diluted EPS $7.78 31 Dec 2025 fiscal year
Total assets $3.3B 30 Jun 2026 at period end
Total equity −$165.4M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

PTCT earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.92
31 Mar 2026 Q1 2026 $-0.03
31 Dec 2025 FY 2025 $7.78
30 Sep 2025 Q3 2025 $0.20

Reported figures & scheduled dates · SEC EDGAR filings

PTCT institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a PTCT position for the quarter ended 31 Mar 2026 — a combined $268.2M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) −6.0% shares 1,640,381 $111.8M
Renaissance Technologies Held (±25%) −12.2% shares 533,300 $36.3M
Marshall Wace Added +85.9% shares 460,638 $31.4M
Balyasny Asset Management New position 460,564 $31.4M
Citadel Advisors Trimmed −66.6% shares 385,199 $26.2M
AQR Capital Management Held (±25%) +0.1% shares 342,106 $23.3M
Fisher Asset Management New position 44,558 $3.0M
Tudor Investment Corp Added +469.0% shares 42,172 $2.9M
Two Sigma Investments Held (±25%) +11.5% shares 27,110 $1.8M

Source: SEC EDGAR 13F filings

PTCT fails-to-deliver

SEC CNS data

On 08 Jul 2026, 29,124 shares of PTCT failed to deliver (about $2.6M).

Settlement date Shares failed Notional % of shares out
08 Jul 2026 29,124 $2.6M 0.035%
30 Jun 2026 124,368 $10.1M 0.149%
26 Jun 2026 11 $930 <0.001%
22 Jun 2026 10 $790 <0.001%
17 Jun 2026 7,985 $585K 0.010%

Source: SEC fails-to-deliver (CNS) data